Screening and intervention of biomarkers for retinitis pigmentosa syndrome

Screening of biomarkers of blood stasis syndrome in deficiency of retinitis pigmentosa and study on intervention effect of wolfberry and salvia miltiorrhiza

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400080794

Enrollment

Unknown

Registered

2024-02-07

Start date

2024-02-18

Completion date

Unknown

Last updated

2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retinitis pigmentosa

Interventions

Liver and kidney Yin deficiency group:NO

Non-liver and kidney Yin deficiency group:NO

Healthy group:NO

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Over 18 years old, meet the diagnostic criteria of Chinese and Western medicine for retinitis pigmentosa or the inclusion criteria of healthy people; Volunteer to participate in this experiment and sign the informed consent.

Exclusion criteria

Exclusion criteria: Patients who meet the diagnostic criteria but have a history of ocular trauma or infection; Patients with a history of eye surgery within six months; Patients with major medical problems. Other conditions deemed inappropriate for participation in this study.

Design outcomes

Primary

Measure	Time frame
Major biomarkers derived from omics analysis;	—

Countries

CHINA

Contacts

Public ContactCHEN OU

The First Affiliated Hospital of Hunan University of Chinese Medicine

465325286@qq.com+86 130 5417 5400

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026